UK to explain regulatory decision-making:
This article was originally published in Clinica
Executive Summary
The UK's Healthcare and products Regulatory Agency, the MHRA, is inviting comments on a document it is drafting that sets out how regulatory decisions are made about medicines and medical devices. In the light of these comments, it will publish a revised version in the summer of 2007. To read the five-page document, see